Aurinia Pharmaceuticals (AUPH) Amortizatization of Intangibles (2020 - 2026)

Aurinia Pharmaceuticals has reported Amortizatization of Intangibles for 7 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles fell 12.69% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $9.8 million (down 19.2% YoY), and the FY2025 full-year result was $10.2 million, down 20.05% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $2.3 million, down from $2.3 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $3.4 million in Q3 2024, with the low at -$211000.0 in Q2 2022.
• Historically, Amortizatization of Intangibles has averaged $2.3 million across 5 years, with a median of $2.6 million in 2025.
• Annual changes were most pronounced in 2022 — Amortizatization of Intangibles tumbled 142.2% — and 2023, when it surged 1965.0%.
• Aurinia Pharmaceuticals' Amortizatization of Intangibles stood at $1.6 million in 2022, then soared by 112.13% to $3.3 million in 2023, then fell by 9.86% to $3.0 million in 2024, then slipped by 21.62% to $2.3 million in 2025, then decreased by 0.69% to $2.3 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.